TEDAVIR

TEDAVIR
Product Description

Dolutegravir/Emtricitabine/Tenofovir Alafenamide Tablets 50/200/25 mg are indicated for use as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 40 kg. In addition to being used for treatment. The product is smaller in size, easier to take, and have fewer side effects on the kidneys.

The Government Pharmaceutical Organization (GPO)

  • Country/Region:
    Thailand
  • On CPHI since:
    2015
  • Certificates:
    1
  • Employees:
    1000 - 4999
Company types
Association/Government
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Specifications
  • Selling Points
    Product Features
  • Supplied from
    Thailand

The Government Pharmaceutical Organization (GPO)

  • Country/Region:
    Thailand
  • On CPHI since:
    2015
  • Certificates:
    1
  • Employees:
    1000 - 4999
Company types
Association/Government
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

More Products from The Government Pharmaceutical Organization (GPO) (2)

  • DALAVIR

    Product DALAVIR

    Dolutegravir/Lamivudine/Tenofovir disoproxil fumarate 50/300/300 mg

    Dolutegravir increases the immune cells that help fight infections in the body and decreases the amount of HIV in the blood.

    WHO recommends Dolutegravir as preferred HIV treat...
  • GPO-L-ONE

    Product GPO-L-ONE

    Deferiprone Tablet 500 mg

    Iron Chelating Agent
    For Treatment of iron overload in thalassemia patients
    Oral Iron Chelator for Good Compliance

    High Affinity for iron Binding

    Effective Removal of Excess Iron from the Body

    Provides Significant Ca...